| Literature DB >> 27099265 |
Peter Willeit1,2,3, Philipp Skroblin1, Stefan Kiechl2, Carlos Fernández-Hernando4, Manuel Mayr5.
Abstract
Recent discoveries have revealed that microRNAs (miRNAs) play a key role in the regulation of gene expression. In this review, we summarize the rapidly evolving knowledge about liver miRNAs (including miR-33, -33*, miR-223, -30c, -144, -148a, -24, -29, and -122) and their link to hepatic lipid metabolism, atherosclerosis and cardiovascular disease, non-alcoholic fatty liver disease, metabolic syndrome, and type-2 diabetes. With regards to its biomarker potential, the main focus is on miR-122 as the most abundant liver miRNA with exquisite tissue specificity. MiR-122 has been proposed to play a central role in the maintenance of lipid and glucose homeostasis and is consistently detectable in serum and plasma. This miRNA may therefore constitute a novel biomarker for cardiovascular and metabolic diseases. Published on behalf of the European Society of Cardiology. All rights reserved.Entities:
Keywords: Biomarkers; Cardiovascular disease; Lipid metabolism; MicroRNAs
Mesh:
Substances:
Year: 2016 PMID: 27099265 PMCID: PMC5146692 DOI: 10.1093/eurheartj/ehw146
Source DB: PubMed Journal: Eur Heart J ISSN: 0195-668X Impact factor: 29.983